出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2016/08/22 19:40:05」(JST)
| Systematic (IUPAC) name | |
|---|---|
|
3-(1-benzyl-1H-indazol-3-yloxy)-N,N-dimethylpropan-1-amine
|
|
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy category |
|
| Routes of administration |
Oral, topical |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Protein binding | <20% |
| Biological half-life | 13 hours |
| Excretion | Renal |
| Identifiers | |
| CAS Number | 642-72-8 Y |
| ATC code | A01AD02 (WHO) G02CC03 (WHO) M01AX07 (WHO) M02AA05 (WHO) |
| PubChem | CID 12555 |
| ChemSpider | 12036 Y |
| UNII | 4O21U048EF Y |
| KEGG | D07516 Y |
| ChEMBL | CHEMBL12610 Y |
| Chemical data | |
| Formula | C19H23N3O |
| Molar mass | 309.405 g/mol |
|
SMILES
|
|
|
InChI
|
|
| (verify) | |
Benzydamine (also known as Tantum Verde and branded in some countries as Difflam), available as the hydrochloride salt, is a locally-acting nonsteroidal anti-inflammatory drug with local anaesthetic and analgesic properties for pain relief and anti-inflammatory treatment of inflammatory conditions of the mouth and throat.[1]
It may be used alone or as an adjunct to other therapy giving the possibility of increased therapeutic effect with little risk of interaction.
In some markets, the drug is supplied as an over-the-counter cream (Lonol in Mexico from Boehringer Ingelheim) used for topical treatment of musculoskeletal system disorders: sprains, strains, bursitis, tendinitis, synovitis, myalgia, periarthritis.
Studies indicate that benzydamine has notable in vitro antibacterial activity and also shows synergism in combination with other antibiotics, especially tetracyclines, against antibiotic-resistant strains of Staphylococcus aureus and Pseudomonas aeruginosa.[2][3]
There are no contraindications to the use of benzydamine except for known hypersensitivity.
Benzydamine is well tolerated. Occasionally oral tissue numbness or stinging sensations may occur, as well as itching, a skin rash, skin swelling or redness, difficulty breathing and wheezing.
It selectively binds to inflamed tissues (Prostaglandin synthetase inhibitor) and is normally free of adverse systemic effects. Unlike other NSAIDs, it does not inhibit cyclooxygenase or lipooxygenase, and is not ulcerogenic.[4]
Benzydamine has been used recreationally. In overdosages it acts a deliriant and CNS stimulant.[4] Such use, particularly among teenagers, has been reported in Poland,[4] Brazil[5][6] and Romania.
Synthesis starts with the reaction of the N-benzyl derivative from methyl anthranilate with nitrous acid to give the N-nitroso derivative. Reduction by means of sodium thiosulfate leads to the transient hydrazine (3), which undergoes spontaneous internal hydrazide formation. Treatment of the enolate of this amide with 3-chloro-1-dimethylamkino propane gives benzydamine (5).
An interesting alternative synthesis of this substance starts by sequential reaction of N-benzylaniline with phosgene, and then with sodium azide to product the corresponding carbonyl azide. On heating, nitrogen is evolved and a separatable mixture of nitrene insertion product and the desired ketoindazole # results. The latter reaction appears to be a Curtius rearrangement type product to produce an N-isocyanate #, which then cyclizes. Alkylation of the enol with sodium methoxide and 3-dimethylaminopropyl chloride gives benzydamine.
Alternatively, use of chloroacetamide in the alkylation step followed by acid hydrolysis produces bendazac instead.
Stomatological preparations (A01)
|
|
|---|---|
| Caries prophylaxis |
|
| Infection and antiseptics |
|
| Corticosteroids (Glucocorticoids) |
|
| Other |
|
Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)
|
|
|---|---|
| Pyrazolones / Pyrazolidines |
|
| Salicylates |
|
| Acetic acid derivatives and related substances |
|
| Oxicams |
|
| Propionic acid derivatives (profens) |
|
| N-Arylanthranilic acids (fenamates) |
|
| Coxibs |
|
| Other |
|
|
Items listed in bold indicate initially developed compounds of specific groups. #WHO-EM †Withdrawn drugs. ‡Veterinary use medications.
|
|
Topical products for joint and muscular pain (M02)
|
|||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Anti-inflammatory preparations, |
|
||||||||||
| Capsaicin derivatives |
|
||||||||||
| Other |
|
||||||||||
Stimulants (N06B)
|
|
|---|---|
| Adamantanes |
|
| Adenosine antagonists |
|
| Alkylamines |
|
| Ampakines |
|
| Arylcyclohexylamines |
|
| Benzazepines |
|
| Cholinergics |
|
| Convulsants |
|
| Eugeroics |
|
| Oxazolines |
|
| Phenethylamines |
|
| Phenylmorpholines |
|
| Piperazines |
|
| Piperidines |
|
| Pyrrolidines |
|
| Racetams |
|
| Tropanes |
|
| Tryptamines |
|
| Others |
|
|
|
Prolactin inhibitors and anti-inflammatory products for vaginal administration (G02CB–G02CC)
|
|
|---|---|
| Prolactin inhibitors |
|
| Anti-inflammatory products for vaginal administration |
|
Hallucinogens
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychedelics (5-HT2A |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dissociatives (NMDAR |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Deliriants (mAChR |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Others |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cholinergics
|
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
|
|||||||||||||||||
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
| リンク元 | 「ベンジダミン」 |
| 拡張検索 | 「benzydamine hydrochloride」 |